FloPatch enables quick haemodynamic evaluations to gauge the fluid responsiveness of the patient. Credit: Flosonics Medical / Business Wire.

FloPatch能够快速进行血流动力学评估，以衡量患者的液体反应性。图片来源：Flosonics Medical / Business Wire。

Canadian company Flosonics Medical has raised C$7.5m ($5.18m) in venture debt financing from financial solutions provider RBCx to expedite the market adoption of the wireless wearable Doppler ultrasound device, FloPatch.

加拿大公司 Flosonics Medical 从金融服务提供商 RBCx 获得了 750 万加元（518 万美元）的风险债务融资，以加速无线可穿戴多普勒超声设备 FloPatch 的市场应用。

The funds will expedite the company’s development of data-driven, non-invasive solutions designed to enhance patient outcomes in critical care settings, particularly for those suffering from sepsis.

这笔资金将加快该公司开发数据驱动、非侵入式的解决方案，旨在改善重症监护环境中的患者预后，特别是对于那些患有败血症的患者。

Go deeper with GlobalData

深入探索GlobalData

Reports

报告

Artificial Intelligence in Healthcare: Physiological Monitoring Fit...

医疗保健中的人工智能：生理监测适配...

Reports

报告

Internet of Things in Healthcare: Physiological Monitoring Fitness ...

医疗保健中的物联网：生理监测健身...

Data Insights

数据洞察

The gold standard of business intelligence.

商业智能的黄金标准。

Find out more

了解更多

FloPatch enables quick haemodynamic evaluations to gauge the patient’s fluid responsiveness. This device aids healthcare providers to optimise sepsis care and minimise fluid-related complications.

FloPatch能够快速进行血流动力学评估，以衡量患者的液体反应性。该设备帮助医疗保健提供者优化脓毒症治疗，并减少与液体相关的并发症。

Through a “user-friendly” interface, the FloPatch app offers a real-time arterial blood velocity trace and an analytics engine that provides haemodynamic metrics.

通过“用户友好型”界面，FloPatch 应用程序提供了实时的动脉血流速度曲线和提供血液动力学指标的分析引擎。

The tech and innovation banking arm of Royal Bank of Canada, RBCx offers debt financing to pre-revenue, venture-backed life sciences companies, supporting them through various stages of growth.

加拿大皇家银行的技术与创新银行部门 RBCx 为尚未盈利、风险投资支持的生命科学公司提供债务融资，支持它们在各个成长阶段的发展。

Anne Woods, managing director of RBCx’s national Life Sciences practice, leads the team providing tailored financing and strategic expertise to foster the next generation of healthcare companies.

安妮·伍兹（Anne Woods），RBCx全国生命科学业务的董事总经理，领导团队提供定制化的融资和战略专业知识，以培育下一代医疗保健公司。

Woods said: “We’re proud to back the scaling ambitions of companies like Flosonics Medical with the capital they need to improve patient care through bold innovations like FloPatch.”

伍兹表示：“我们很自豪能够支持像 Flosonics Medical 这样的公司实现扩展雄心，为他们提供改善患者护理所需的资金，通过像 FloPatch 这样大胆的创新。”

Flosonics Medical CEO and co-founder Joe Eibl said: “We’re thrilled to be working with RBCx as we bring FloPatch to more hospitals across North America and beyond.

弗洛森医学公司首席执行官兼联合创始人乔·艾布尔表示：“我们很高兴能与RBCx合作，将FloPatch推广到北美及其他地区的更多医院。

“This financing allows us to accelerate our mission of equipping healthcare providers with the tools they need to deliver the highest quality of care possible while improving operational efficiencies in hospitals.”

“这笔资金使我们能够加快实现为医疗保健提供者配备所需工具的使命，以便在提高医院运营效率的同时提供尽可能高质量的护理。”

Flosonics Medical focuses on ultrasound technology’s research and development, aiming to enhance patient care and medical practice via technological solutions and clinical research.

弗洛森医学专注于超声技术的研究与开发，旨在通过技术解决方案和临床研究改善患者护理和医疗实践。

Sign up for our daily news round-up!

注册获取我们的每日新闻汇总！

Give your business an edge with our leading industry insights.

利用我们领先的行业洞察，为您的企业赢得优势。

Sign up

注册

Share

分享

Copy Link

复制链接

Share on X

分享到X

Share on Linkedin

分享到领英

Share on Facebook

分享到 Facebook